Liv Vernstrøm (L Vernstrøm)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Diffusion Weighted

Top Venues

Diabetes, obesity & metabolism

Diabetic medicine : a journal of the British Diabetic Association

This page only lists publications with an associated author ORCID identifier.

Publications

Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian Løkke Funck, Per Løgstrup Poulsen, Esben Laugesen
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia (2024)
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Kristian Løkke Funck, Esben Laugesen, Per L Poulsen
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial. Diabetes, obesity & metabolism 26 (5) (2024)
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Kristian Løkke Funck, Esben Laugesen, Per L Poulsen
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial. Diabetes, obesity & metabolism (2024)
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Kristian Løkke Funck, Esben Laugesen, Per L Poulsen
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial. Diabetes, obesity & metabolism 26 (5) (2024)
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Henrik Birn, Kristian Løkke Funck, Esben Laugesen, Per Løgstrup Poulsen
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial. Diabetologia (2024)
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian Løkke Funck, Per Løgstrup Poulsen, Esben Laugesen
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia (2023)
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian Løkke Funck, Per Løgstrup Poulsen, Esben Laugesen
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia 66 (5) (2023)
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian Løkke Funck, Per Løgstrup Poulsen, Esben Laugesen
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia 66 (5) (2023)
Liv Vernstrøm, E Laugesen, E L Grove, J M Baier, S Gullaksen, A-M Hvas, P L Poulsen, Kristian Løkke Funck
Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetes. Diabetic medicine : a journal of the British Diabetic Association 36 (9) (2019)